Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.132 AUD 0.00(0%)
Last update at 2026-11-06T04:55:00Z
VOLUME
94411
Market Cap
19.00M

Momentum Score

…

McPherson's Limited operates as a health and beauty company in Australia, New Zealand, Asia, and internationally. The company offers beauty care; hair care; skin care; footwear; vitamins and supplements; fragrance and nutrition products; and personal care items, including facial wipes, cotton pads, and foot comfort products. It sells its products under the A'kin, Dr. LeWinn's, Lady Jayne, Manicare, Glam by Manicare, Swisspers, Revitanail, Maseur, Footcare by Maseur, Fusion Health, and Bondi brand names. The company was founded in 1860 and is headquartered in Sydney, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.13
Low
0.14
High
52 Week Price Range
0.12
Low
0.25
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

McPhersons Ltd is an Australian consumer goods company that markets and distributes health, beauty and household products through retail and online channels domestically and in selected export markets. Long-term growth may come from rising demand for self-care, e-commerce expansion and distribution partnerships, offering investors exposure to established consumer brands and recurring retail demand.
Principal risks are intense competition from global and private-label players, reliance on a limited set of retail partners and suppliers, and vulnerability to supply-chain, currency and execution challenges that could weigh on sales and margins.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.13
Dividend Yield
-
Revenue TTM
118.31M
Revenue Per Share
0.83
Gross Profit TTM
69.60M
Debt / Equity
0.12
ROE
-32.48%
Net Debt
1.08M
ROCE
-8.80%
Diluted EPS TTM
-0.14

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -25.67M -19.67M -12.74M -4.67M 0.44M
Net income -20.26M -15.04M -15.99M -5.06M 0.33M
Selling general administrative - 41.07M 35.86M 39.32M 39.60M
Selling and marketing expenses - 27.69M 26.96M 32.25M 29.18M
Gross profit 39.72M 80.45M 35.09M 103.07M 90.80M
Reconciled depreciation - 6.55M 5.91M 5.99M 5.67M
Ebit -4.85M -10.05M -10.83M 8.58M 1.61M
Ebitda -0.66M -6.99M -4.92M 14.56M 7.29M
Depreciation and amortization 4.19M 3.07M 5.91M 5.99M 5.67M
Operating income -4.85M -10.07M -8.18M 8.55M 1.03M
Other operating expenses 123.16M 157.97M 152.80M 0.96M 33.71M
Interest expense 0.46M 0.95M 1.91M 1.79M 1.18M
Tax provision - -3.07M -1.35M 0.39M 0.10M
Interest income - 0.25M 0.08M 0.02M 0.03M
Net interest income - -0.70M -1.83M -1.76M -1.14M
Extraordinary items - 1.56M -4.61M - -
Income tax expense -5.41M 3.07M -1.35M 0.39M 0.10M
Total revenue 118.31M 138.99M 144.62M 210.26M 214.00M
Total operating expenses 44.56M 99.43M 43.26M 94.58M 89.92M
Cost of revenue 78.59M 58.54M 109.54M 107.19M 123.20M
Total other income expense net -20.82M -9.60M -4.56M -11.40M 0.70M
Net income from continuing ops - -16.60M -11.39M -5.06M 0.33M
Net income applicable to common shares - -15.04M -15.99M -5.06M 0.33M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 96.91M 117.21M 146.90M 187.20M 212.03M
Intangible assets 20.46M 27.15M - 45.09M 56.82M
Other current assets 1.32M 0.96M 0.82M 0.99M 0.85M
Total liab 45.14M 44.23M 57.26M 77.75M 91.23M
Total stockholder equity 51.77M 72.98M 89.64M 109.45M 120.81M
Other current liab 9.81M - 13.26M 33.83M 45.27M
Common stock 216.39M - 217.22M 217.22M 207.24M
Capital stock - 217.22M - 217.22M 207.24M
Retained earnings -167.41M -147.15M -126.11M -105.80M -94.98M
Other liab - - - 9.73M 10.68M
Good will 3.99M 19.02M 23.73M 33.73M 33.64M
Other assets - - - 7.59M 9.12M
Cash 5.11M 9.48M 24.77M 7.03M 13.14M
Total current liabilities 41.82M 37.79M 46.73M 47.23M 69.62M
Current deferred revenue 20.88M - 12.37M -4.66M -18.46M
Net debt 1.08M - -5.13M 18.42M 16.24M
Short term debt 3.25M - 14.07M 4.66M 18.46M
Short long term debt - 0.66M - 0.93M 14.89M
Short long term debt total 6.19M - 19.64M 25.45M 29.38M
Other stockholder equity - - - -111.42M -112.26M
Property plant equipment - - - 18.11M 19.68M
Total current assets 63.15M 60.65M 75.78M 82.68M 92.77M
Net tangible assets - - - 30.64M 30.34M
Short term investments - - - - 0.36M
Net receivables 30.50M 25.89M 24.53M 28.89M 29.76M
Long term debt - - - 12.59M 0.00M
Inventory 26.22M 19.79M 25.66M 45.16M 45.54M
Accounts payable 7.88M 6.01M 7.03M 13.39M 24.35M
Accumulated other comprehensive income 2.79M - -1.47M -1.97M 8.54M
Non currrent assets other - 1.01M 32.92M 7.59M 8.85M
Non current assets total 33.76M 56.56M 71.12M 104.52M 119.27M
Capital lease obligations - 6.64M - 11.93M 14.49M
Long term debt total - - - 20.79M 10.92M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -3.62M 16.29M -1.85M -2.25M
Change to liabilities - - - -9.25M 1.56M
Total cashflows from investing activities -1.29M -3.62M 16.29M -1.85M -2.25M
Net borrowings - -10.20M -3.04M -5.15M -4.80M
Total cash from financing activities -3.78M -13.91M -10.90M -10.91M -10.59M
Change to operating activities - - - -0.49M 0.25M
Net income -20.26M -15.04M -15.99M -5.06M 0.33M
Change in cash -4.37M -15.29M 17.74M -6.11M 5.79M
Begin period cash flow 9.48M 24.77M 7.03M 13.14M 7.35M
End period cash flow 5.11M 9.48M 24.77M 7.03M 13.14M
Total cash from operating activities 0.68M 2.21M 12.34M 6.55M 18.57M
Depreciation 4.19M 6.55M 5.91M 5.99M 5.67M
Other cashflows from investing activities - -2.98M 17.43M - -
Dividends paid - 0.00M -4.32M -5.76M -5.79M
Change to inventory -6.42M 6.24M 10.46M 0.43M 2.49M
Change to account receivables 1.55M -5.14M 4.81M 0.77M 7.83M
Sale purchase of stock -0.81M - - -0.00M -0.00M
Other cashflows from financing activities -2.90M -10.20M -3.54M -3.78M -3.92M
Change to netincome - - - 12.47M 0.54M
Capital expenditures 0.72M 0.64M 2.71M 1.85M 2.25M
Change in working capital -5.53M -0.64M 13.87M 1.20M 10.32M
Stock based compensation - -0.40M 0.54M -0.10M 0.38M
Other non cash items 22.28M 11.73M 8.02M 5.62M 12.57M
Free cash flow -0.05M 1.57M 9.64M 4.70M 16.32M

Peer Comparison*

Sector: Consumer Defensive Industry: Household & Personal Products

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MCP
Mcphersons Ltd
-
-%
0.13 - 16.08 0.16 0.36 0.17 16.32
S66
Star Combo Pharma Ltd
-0.04
20.00%
0.14 - - 0.80 0.61 0.42 4.45
ZNO
ZOONO Group Ltd
-0.00
5.00%
0.04 - 8.88 9.73 5.76 11.89 -1.38
SKN
Skin Elements Ltd
-
-%
0.00 - - 30.26 8.04 27.95 -0.22
AN1
Anagenics Ltd
0.00
20.00%
0.01 - 4.97 0.95 1.17 1.14 7.77

Profile*

Mcphersons Ltd

McPherson's Limited operates as a health and beauty company in Australia, New Zealand, Asia, and internationally. The company offers beauty care; hair care; skin care; footwear; vitamins and supplements; fragrance and nutrition products; and personal care items, including facial wipes, cotton pads, and foot comfort products. It sells its products under the A'kin, Dr. LeWinn's, Lady Jayne, Manicare, Glam by Manicare, Swisspers, Revitanail, Maseur, Footcare by Maseur, Fusion Health, and Bondi brand names. The company was founded in 1860 and is headquartered in Sydney, Australia.

383 Kent Street, Sydney, NSW, Australia, 2000

61 2 9370 8000

Name Title Year Born
Mr. Grant W. Peck C.A. MD, CEO & Director NA
Mr. Paul Witheridge B.Com, B.Com., C.A., CA CFO & Joint Company Sec. NA
Ms. Lori Pirozzi National Accounts Director NA
Donna Chan Marketing Director NA
Ms. Lisa Sheehan Chief People Officer NA
Mr. Philip R. Bennett BCom, CA Joint Company Sec. NA
Mr. Sammy K. S. Chan Managing Director of McPherson's Hong Kong Limited NA
David Fielding Director of Strategy, Planning and Innovation NA
Mary Pearce R&D Director NA
Dawn Swainston Gen. Mang. of Health NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…